Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 5/2020

27.11.2019 | Substantive Review

Intimate Partner Violence and Pre-exposure Prophylaxis (PrEP): A Rapid Review of Current Evidence for Women’s HIV Prevention

verfasst von: Teagen L. O’Malley, Mary E. Hawk, James E. Egan, Sarah E. Krier, Jessica G. Burke

Erschienen in: AIDS and Behavior | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Pre-exposure prophylaxis (PrEP) is a valued component of HIV prevention and increasing attention is focusing on women’s PrEP use. Common HIV prevention options (e.g., condoms) remain underused and fail to consider the context of intimate partner violence (IPV). PrEP presents an opportunity to expand viable options for women. A systematic rapid review using key word searches of PubMed and proceedings from six national and international conferences related to HIV, women’s health, or interpersonal violence identified nine studies which met set inclusion criteria. Studies were coded using a structured abstraction form and summarized according to relevant themes. IPV was found to have implications on women’s interest and willingness to use PrEP, partner interference or interruptions in PrEP use, and adherence. Findings indicate a dearth of research on women’s PrEP use and IPV and highlight the urgency for research, public heath practice, and policy attention around the HIV risk context and needs of women who experience IPV.
Literatur
1.
2.
World Health Organization. Violence against women and HIV/AIDS: intimate partner violence and HIV/AIDS. Geneva: World Health Organization; 2004.
3.
4.
Centers for Disease Control and Prevention. HIV infection, risk, prevention, and testing behaviors among heterosexuals at increased risk of HIV infection. National HIV Behavioral Surveillance, 20 U.S. Cities. 2013.
5.
World Health Organization. Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and nonpartner sexual violence. Geneva: World Health Organization; 2013.
6.
World Health Organization. Understanding and addressing violence against women. Geneva: World Health Organization; 2012.
7.
Campbell JC. Health consequences of intimate partner violence. Lancet. 2002;359(9314):1331–6.PubMed
8.
Chandra PS, Satyanarayana VA, Carey MP. Women reporting intimate partner violence in India: associations with PTSD and depressive symptoms. Arch Women Mental Health. 2009;12(4):203–9.
9.
Ellsberg M, Jansen HA, Heise L, Watts CH, Garcia-Moreno C. Intimate partner violence and women’s physical and mental health in the WHO multi-country study on women’s health and domestic violence: an observational study. Lancet. 2008;371(9619):1165–72.PubMed
10.
Varma D, Chandra PS, Thomas T, Carey MP. Intimate partner violence and sexual coercion among pregnant women in India: relationship with depression and post-traumatic stress disorder. J Affect Disord. 2007;102(1–3):227–35.PubMed
11.
Coker AL, Davis KE, Arias I, Desai S, Sanderson M, Brandt HM, et al. Physical and mental health effects of intimate partner violence for men and women. Am J Prev Med. 2002;23(4):260–8.PubMed
12.
Kinyanda E, Weiss HA, Mungherera M, Onyango-Mangen P, Ngabirano E, Kajungu R, et al. Intimate partner violence as seen in post-conflict eastern Uganda: prevalence, risk factors and mental health consequences. BMC Int Health Hum Rights. 2016;16(1):5.PubMedPubMedCentral
13.
Pallitto CC, Garcia-Moreno C, Jansen HA, Heise L, Ellsberg M, Watts C. Intimate partner violence, abortion, and unintended pregnancy: results from the WHO multi-country study on women’s health and domestic violence. Int J Gynaecol Obstet. 2013;120(1):3–9.PubMed
14.
Antai D, Antai J, Anthony DS. The relationship between socio-economic inequalities, intimate partner violence and economic abuse: a national study of women in the Philippines. Glob Public Health. 2014;9(7):808–26.PubMed
15.
Matheson FI, Daoud N, Hamilton-Wright S, Borenstein H, Pedersen C, O’Campo P. Where did she go? The transformation of self-esteem, self-identity, and mental well-being among women who have experienced intimate partner violence. Women Health Issues. 2015;25(5):561–9.
16.
Campbell JC, Baty ML, Ghandour RM, Stockman JK, Francisco L, Wagman J. The intersection of intimate partner violence against women and HIV/AIDS: a review. Int J Inj Control Saf Promot. 2008;15(4):221–31.
17.
Gielen AC, Ghandour RM, Burke JG, Mahoney P, McDonnell KA, O’Campo P. HIV/AIDS and intimate partner violence: intersecting women’s health issues in the United States. Trauma Violence Abus. 2007;8(2):178–98.
18.
Li Y, Marshall CM, Rees HC, Nunez A, Ezeanolue EE, Ehiri JE. Intimate partner violence and HIV infection among women: a systematic review and meta-analysis. J Int AIDS Soc. 2014;17:18845.PubMedPubMedCentral
19.
Phillips DY, Walsh B, Bullion JW, Reid PV, Bacon K, Okoro N. The intersection of intimate partner violence and HIV in U.S. women: a review. J Assoc Nurses AIDS Care. 2014;25(1 Suppl):S36–49.PubMed
20.
Maman S, Campbell J, Sweat MD, Gielen AC. The intersections of HIV and violence: directions for future research and interventions. Soc Sci Med. 2000;50(4):459–78.PubMed
21.
Dunkle KL, Decker MR. Gender-based violence and HIV: reviewing the evidence for links and causal pathways in the general population and high-risk groups. Am J Reprod Immunol. 2013;69(Suppl 1):20–6.PubMed
22.
Stockman JK, Lucea MB, Campbell JC. Forced sexual initiation, sexual intimate partner violence and HIV risk in women: a global review of the literature. AIDS Behav. 2013;17(3):832–47.PubMedPubMedCentral
23.
Coker AL. Does physical intimate partner violence affect sexual health? A systematic review. Trauma Violence Abus. 2007;8(2):149–77.
24.
Dude A. Intimate partner violence and increased lifetime risk of sexually transmitted infection among women in Ukraine. Stud Fam Plann. 2007;38(2):89–100.PubMed
25.
Wingood GM, DiClemente RJ, Raj A. Identifying the prevalence and correlates of STDs among women residing in rural domestic violence shelters. Women Health. 2000;30(4):15–26.PubMed
26.
Choi KH, Wojcicki J, Valencia-Garcia D. Introducing and negotiating the use of female condoms in sexual relationships: qualitative interviews with women attending a family planning clinic. AIDS Behav. 2004;8(3):251–61.PubMed
27.
Saul J, Moore J, Murphy ST, Miller LC. Relationship violence and women’s reactions to male- and female-controlled HIV prevention methods. AIDS Behav. 2004;8(2):207–14.PubMed
28.
Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction. J Int AIDS Soc. 2015;18:20536.PubMedPubMedCentral
29.
30.
31.
Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973–83.PubMedPubMedCentral
32.
World Health Organization. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection module 1: clinical. Geneva: World Health Organization; 2017.
33.
Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325–35.PubMed
34.
Chen NE, Meyer JP, Springer SA. Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States. Infect Dis Rep. 2011;3:1.
35.
Rubtsova A, Wingood GM, Dunkle K, Camp C, DiClemente RJ. Young adult women and correlates of potential adoption of pre-exposure prophylaxis (PrEP): results of a national survey. Curr HIV Res. 2013;11(7):543–8.PubMedPubMedCentral
36.
Braksmajer A, Senn TE, McMahon J. The potential of pre-exposure prophylaxis for women in violent relationships. AIDS Patient Care STDs. 2016;30(6):274–81.PubMedPubMedCentral
37.
38.
Bergmann JN, Stockman JK. How does intimate partner violence affect condom and oral contraceptive use in the United States? A systematic review of the literature. Contraception. 2015;91(6):438–55.PubMedPubMedCentral
39.
Decker MR, Miller E, McCauley HL, Tancredi DJ, Anderson H, Levenson RR, et al. Recent partner violence and sexual and drug-related STI/HIV risk among adolescent and young adult women attending family planning clinics. Sex Transm Infect. 2014;90(2):145–9.PubMed
40.
Flash CA, Stone VE, Mitty JA, Mimiaga MJ, Hall KT, Krakower D, et al. Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis. AIDS Patient Care STDs. 2014;28(12):635–42.PubMedPubMedCentral
41.
Stockman JK, Syvertsen JL, Robertson AM, Ludwig-Barron NT, Bergmann JN, Palinkas LA. Women’s perspectives on female-initiated barrier methods for the prevention of HIV in the context of methamphetamine use and partner violence. Women’s Health Issues. 2014;24(4):e397–405.PubMedPubMedCentral
42.
Weeks MR, Mosack KE, Abbott M, Sylla LN, Valdes B, Prince M. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention. Sex Transm Dis. 2004;31(11):682–90.PubMedPubMedCentral
43.
Wingood GM, DiClemente RJ. The effects of an abusive primary partner on the condom use and sexual negotiation practices of African-American women. Am J Public Health. 1997;87(6):1016–8.PubMedPubMedCentral
44.
Eakle R, Bourne A, Jarrett C, Stadler J, Larson H. Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography. BMC Public Health. 2017;17(1):968.PubMedPubMedCentral
45.
Tricco AC, Langlois EV, Straus SE. Rapid reviews to strengthen health policy and systems: a practical guide. Geneva: World Health Organization; 2017.
46.
Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV? A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.PubMed
47.
Kelly JA. Scientific meeting abstracts: significance, access, and trends. Bull Med Libr Assoc. 1998;86(1):68–76.PubMedPubMedCentral
48.
Evidence Partners. DistillerSR. Ottawa: Evidence Partners; 2019.
49.
Braksmajer A, Leblanc NM, El-Bassel N, Urban MA, McMahon JM. Feasibility and acceptability of pre-exposure prophylaxis use among women in violent relationships. AIDS Care. 2018;31:475–80.PubMed
50.
Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, et al. Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: a prospective cohort study. J Acquir Immune Defic Syndr. 2016;73(3):313–22.PubMedPubMedCentral
51.
Willie T, Kershaw T, Campbell JC, Alexander KA. Intimate partner violence and PrEP acceptability among low-income, young black women: exploring the mediating role of reproductive coercion. AIDS Behav. 2017;21(8):2261–9.PubMedPubMedCentral
52.
Willie TC, Stockman JK, Keene DE, Calabrese SK, Alexander KA, Kershaw TS. Social networks and its impact on women’s awareness, interest, and uptake of HIV pre-exposure prophylaxis (PrEP): implications for women experiencing intimate partner violence. J Acquir Immune Defic Syndr. 2018;80:386–93.
53.
Willie TC, Stockman JK, Overstreet NM, Kershaw TS. Examining the Impact of intimate partner violence type and timing on pre-exposure prophylaxis awareness, interest, and coercion. AIDS Behav. 2017;22:1190–200.
54.
Hartmann M, Montgomery E, Stadler J, Laborde N, Magazi B, Mathebula F, et al. Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape. Cult Health Sex. 2016;18(6):611–24.PubMed
55.
Hartmann M, Palanee-Phillips T, O’Rourke S, Adewumi K, Tenza S, Mathebula F, et al. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa. AIDS Care. 2018;31:600–66.
56.
Colombini MB, Ramskin L, Khoza N, Stangl A, Scorgie F, Harvey S, et al. Integrating gender-based violence screening and support into HIV counselling and testing for adolescent girls and young women accessing PrEP in South Africa and Tanzania—experiences from the EMPOWER study. In: International AIDS conference (AIDS), July 23–27, Amsterdam, The Netherlands 2018.
57.
Cabral A, Baeten J, Ngure K, Velloza J, Odoyo J, Haberer J, et al. Intimate partner violence and self-reported pre-exposure prophylaxis interruptions among HIV-negative partners in HIV serodiscordant couples in Kenya and Uganda. J Acquir Immune Defic Syndr. 2018;77(2):154–9.PubMedPubMedCentral
58.
Bailey JL, Molino ST, Vega AD, Badowski M. A review of HIV pre-exposure prophylaxis: the female perspective. Infect Dis Ther. 2017;6(3):363–82.PubMedPubMedCentral
59.
Andersson N. Prevention for those who have freedom of choice—or among the choice-disabled: confronting equity in the AIDS epidemic. AIDS Res Ther. 2006;3:23.PubMedPubMedCentral
60.
Kofman A, Adashi EY. Pre-exposure prophylaxis for the primary prevention of HIV in at-risk women: empowerment and equity revisited. AIDS Rev. 2014;16:134–43.PubMed
61.
Van der Wal R, Loutfi D. Pre-exposure prophylaxis for HIV prevention in East and Southern Africa. Can J Public Health (Rev Can Sante Publique). 2018;108(5–6):e643–5.
62.
Garfinkel DB, Alexander KA, McDonald-Mosley R, Willie TC, Decker MR. Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care. 2017;29(6):751–8.PubMed
63.
Gallo MF, Kilbourne-Brook M, Coffey PS. A review of the effectiveness and acceptability of the female condom for dual protection. Sex Health. 2012;9(1):18–26.PubMed
64.
Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers and costs: potential barriers to PrEP uptake among U.S. women. J AIDS Clin Res. 2017;8:9.
65.
Artz L, Demand M, Pulley L, Posner SF, Macaluso M. Predictors of difficulty inserting the female condom. Contraception. 2002;65(2):151–7.PubMed
66.
Artz L, Macaluso M, Brill I, Kelaghan J, Austin H, Fleenor M, et al. Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. Am J Public Health. 2000;90(2):237–44.PubMedPubMedCentral
67.
Sly DF, Quadagno D, Harrison DF, Eberstein IW, Riehman K, Bailey M. Factors associated with use of the female condom. Fam Plann Perspect. 1997;29(4):181–4.PubMed
68.
Hoffman S, Mantell J, Exner T, Stein Z. The future of the female condom. Perspect Sex Reprod Health. 2004;36(3):120–6.PubMed
69.
Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among U.S. women at risk of acquiring HIV. AIDS Patient Care STDs. 2015;29(2):102–10.PubMedPubMedCentral
70.
Aaron E, Blum C, Seidman D, Hoyt MJ, Simone J, Sullivan M, et al. Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care STDs. 2018;32(1):16–23.PubMedPubMedCentral
71.
Collier KL, Colarossi LG, Sanders K. Raising awareness of pre-exposure prophylaxis (PrEP) among women in New York City: community and provider perspectives. J Health Commun. 2017;22(3):183–9.PubMed
72.
Hoover K, editor. Women and PrEP implementation. U.S. Women & PrEP Working Group, 2014 June 30, 2014.
73.
Frost JJ. U.S. Women’s use of sexual and reproductive health services: trends, sources of care and factors associated with use, 1995–2010. New York: Guttmacher Institute; 2013.
74.
Frost JJ, Gold RB, Bucek A. Specialized family planning clinics in the United States: why women choose them and their role in meeting women’s health care needs. Women’s Health Issues. 2012;22(6):e519–25.PubMed
75.
Tricco AC, Antony J, Zarin W, Strifler L, Ghassemi M, Ivory J, et al. A scoping review of rapid review methods. BMC Med. 2015;13:224.PubMedPubMedCentral
Metadaten
Titel
Intimate Partner Violence and Pre-exposure Prophylaxis (PrEP): A Rapid Review of Current Evidence for Women’s HIV Prevention
verfasst von
Teagen L. O’Malley
Mary E. Hawk
James E. Egan
Sarah E. Krier
Jessica G. Burke
Publikationsdatum
27.11.2019
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 5/2020
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02743-x

Weitere Artikel der Ausgabe 5/2020

AIDS and Behavior 5/2020 Zur Ausgabe

Original Paper

Preferences for Pre-exposure Prophylaxis Service Delivery Among Female Sex Workers in Malawi: A Discrete Choice Experiment

Original Paper

Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial

Original Paper

SMARTtest: A Smartphone App to Facilitate HIV and Syphilis Self- and Partner-Testing, Interpretation of Results, and Linkage to Care

Original Paper

Effects of a Combined Exercise Training Program on Health Indicators and Quality of Life of People Living with HIV: A Randomized Clinical Trial

Original Paper

Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018

Original Paper

Acceptance and Feasibility of Partner Notification to HIV Infected Individuals in Guinea-Bissau

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise